About Keno Gutierrez
Form D filings for Brenig Therapeutics in 2024 list Keno Gutierrez as director.
Keno Gutierrez first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Keno Gutierrez in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Keno Gutierrez works with at each company, as listed on that company's latest Form D.
Brenig Therapeutics, Inc. · Form D, Jul 30, 2024
ID
Iain Dukes
Executive officer and director
EM
Edward Mathers
Director
NS
Nikolay Savchuk
Chief Executive Officer and director
MC
Michele Cucullu
Director